Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is a publicly traded biotechnology corporation listed on the Nasdaq stock exchange, meaning it is not owned by a single parent company. Its corporate ownership structure is distributed among institutional asset management firms, prominent hedge funds (such as Knoll Capital Management and Perceptive Advisors), corporate insiders, and public retail shareholders.